Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Butantan-DV in Healthy Adults
NCT01696422Phase 2Unknown
- Sponsor
- Instituto Butantan
- Start
- Oct 2013
- Primary completion
- Apr 2016
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Butantan-DV in dengue fever, sponsored by Instituto Butantan. Status: unknown.
02
Drugs
Butantan-DV
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT01696422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01696422.